InfuSystem Holdings, Inc. (INFU)
USD 8.26
(-8.93%)
USD 8.26
(-8.93%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 16.59 Million USD | 11.44% |
| 2022 | 15.09 Million USD | -13.71% |
| 2021 | 17.15 Million USD | -24.38% |
| 2020 | 22.82 Million USD | 44.72% |
| 2019 | 15.77 Million USD | 34.95% |
| 2018 | 11.68 Million USD | 21.84% |
| 2017 | 8.59 Million USD | -18.19% |
| 2016 | 11.72 Million USD | -31.52% |
| 2015 | 13.93 Million USD | 10.55% |
| 2014 | 15.48 Million USD | 8.83% |
| 2013 | 14.23 Million USD | 38.68% |
| 2012 | 9.45 Million USD | -0.22% |
| 2011 | -57.33 Million USD | 34.29% |
| 2010 | 7.74 Million USD | -34.97% |
| 2009 | 11.69 Million USD | 4.9% |
| 2008 | 20.39 Million USD | 322.19% |
| 2007 | -635 Thousand USD | 110.65% |
| 2006 | -6.82 Million USD | -101865.31% |
| 2005 | -24.48 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 4.88 Million USD | 137.51% |
| 2024 Q1 | 2.05 Million USD | -53.16% |
| 2023 Q2 | 4.34 Million USD | 41.88% |
| 2023 FY | - USD | 11.44% |
| 2023 Q4 | 4.39 Million USD | -7.51% |
| 2023 Q1 | 3.06 Million USD | 127.58% |
| 2023 Q3 | 4.75 Million USD | 9.39% |
| 2022 Q3 | 4.37 Million USD | 22.23% |
| 2022 Q1 | 2.86 Million USD | 11.66% |
| 2022 FY | - USD | -13.71% |
| 2022 Q4 | 1.34 Million USD | -69.24% |
| 2022 Q2 | 3.57 Million USD | 24.94% |
| 2021 Q2 | 4.31 Million USD | -1.28% |
| 2021 Q4 | 2.56 Million USD | -23.35% |
| 2021 FY | - USD | -24.38% |
| 2021 Q1 | 4.37 Million USD | -4.06% |
| 2021 Q3 | 3.34 Million USD | -22.53% |
| 2020 Q1 | 1.08 Million USD | -53.88% |
| 2020 FY | - USD | 44.72% |
| 2020 Q4 | 4.55 Million USD | -33.16% |
| 2020 Q3 | 6.82 Million USD | 22.42% |
| 2020 Q2 | 5.57 Million USD | 411.66% |
| 2019 Q4 | 2.36 Million USD | -13.48% |
| 2019 FY | - USD | 34.95% |
| 2019 Q1 | 684 Thousand USD | -45.06% |
| 2019 Q2 | 2.05 Million USD | 200.58% |
| 2019 Q3 | 2.72 Million USD | 32.73% |
| 2018 FY | - USD | 21.84% |
| 2018 Q3 | 1.05 Million USD | 9.77% |
| 2018 Q2 | 962 Thousand USD | -45.46% |
| 2018 Q1 | 1.76 Million USD | 66.73% |
| 2018 Q4 | 1.24 Million USD | 17.9% |
| 2017 Q4 | 1.05 Million USD | -45.35% |
| 2017 Q2 | 229 Thousand USD | 138.49% |
| 2017 FY | - USD | -18.19% |
| 2017 Q1 | -595 Thousand USD | -201.19% |
| 2017 Q3 | 1.93 Million USD | 745.41% |
| 2016 FY | - USD | -31.52% |
| 2016 Q4 | 588 Thousand USD | -61.52% |
| 2016 Q1 | 2.09 Million USD | -48.99% |
| 2016 Q2 | 2.31 Million USD | 10.21% |
| 2016 Q3 | 1.52 Million USD | -33.85% |
| 2015 Q1 | 2.2 Million USD | -35.25% |
| 2015 FY | - USD | 10.55% |
| 2015 Q4 | 4.1 Million USD | 20.15% |
| 2015 Q3 | 3.42 Million USD | 68.47% |
| 2015 Q2 | 2.03 Million USD | -7.81% |
| 2014 Q2 | 3 Million USD | 25.75% |
| 2014 FY | - USD | 8.83% |
| 2014 Q4 | 3.4 Million USD | 10.85% |
| 2014 Q3 | 3.06 Million USD | 2.16% |
| 2014 Q1 | 2.38 Million USD | -22.42% |
| 2013 Q1 | 1.63 Million USD | -27.67% |
| 2013 Q2 | 1.53 Million USD | -6.05% |
| 2013 Q3 | 2.56 Million USD | 66.82% |
| 2013 FY | - USD | 38.68% |
| 2013 Q4 | 3.07 Million USD | 20.05% |
| 2012 Q4 | 2.26 Million USD | -25.37% |
| 2012 Q1 | 1.61 Million USD | 10.01% |
| 2012 Q2 | 703 Thousand USD | -56.5% |
| 2012 Q3 | 3.03 Million USD | 331.15% |
| 2012 FY | - USD | -0.22% |
| 2011 FY | - USD | 34.29% |
| 2011 Q4 | 1.46 Million USD | -55.36% |
| 2011 Q3 | 3.29 Million USD | 6.37% |
| 2011 Q2 | 3.09 Million USD | 27.33% |
| 2011 Q1 | 2.43 Million USD | -20.64% |
| 2010 Q2 | 977 Thousand USD | -53.16% |
| 2010 FY | - USD | -34.97% |
| 2010 Q4 | 3.06 Million USD | 99.74% |
| 2010 Q3 | 1.53 Million USD | 56.91% |
| 2010 Q1 | 2.08 Million USD | -32.29% |
| 2009 FY | - USD | 4.9% |
| 2009 Q4 | 3.08 Million USD | 1.95% |
| 2009 Q3 | 3.02 Million USD | 2.89% |
| 2009 Q2 | 2.93 Million USD | 7.35% |
| 2009 Q1 | 2.73 Million USD | -62.41% |
| 2008 Q4 | 7.27 Million USD | 713.66% |
| 2008 FY | - USD | 322.19% |
| 2008 Q1 | -3.06 Million USD | -110.18% |
| 2008 Q2 | 4.65 Million USD | 251.61% |
| 2008 Q3 | -1.18 Million USD | -125.49% |
| 2007 Q1 | -2.26 Million USD | -186.06% |
| 2007 Q4 | 30.14 Million USD | 4739.23% |
| 2007 FY | - USD | 110.65% |
| 2007 Q3 | 622.88 Thousand USD | -67.03% |
| 2007 Q2 | 1.88 Million USD | 183.39% |
| 2006 Q2 | -177.88 Thousand USD | -30943.63% |
| 2006 Q4 | -791.98 Thousand USD | 94.0% |
| 2006 FY | - USD | -101865.31% |
| 2006 Q3 | -13.19 Million USD | -7317.11% |
| 2006 Q1 | -573.00 USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Milestone Scientific Inc. | -6.95 Million USD | 338.596% |
| Retractable Technologies, Inc. | -1.23 Million USD | 1441.843% |
| Stereotaxis, Inc. | -21.24 Million USD | 178.121% |